Wadden, PhDand funded by Novo Nordisk, the maker of semaglutidefound that GLP-1 users without known psychopathology werent any more likely to develop depression or suicidal thoughts or actions than controls
These are the best available estimates, but individual responses vary
Tirzepatide is not typically included in standard drug screening panels
As AUD is a heterogeneous disorder with a multifaceted pathophysiology, the possibility that combinations of GLP-1 and other gutbrain axis peptides synergistically reduce alcohol drinking should be explored in future studies
Did You Know: The practice of combining multiple peptides for synergistic effects draws inspiration from the bodys own regenerative processes, which involve coordinated activity of numerous signaling molecules
This pathological ROS overproduction is a common final pathway in various forms of acquired hearing loss, including noise-induced and drug-induced (cisplatin) hearing impairment, and current evidence from human studies supporting antioxidant-based interventions remains insufficient (Teraoka et al., 2024)
